Study of Aritinercept in Patients With Generalized Myasthenia Gravis

Summary

This clinical study will enroll patients with generalized myasthenia gravis (gMG). The goal of this clinical study is to assess the safety, tolerability, effectiveness, pharmacokinetics (how the body processes the drug) and pharmacodynamics (how the drug affects the body) of aritinercept.

Timeline

Start

2026-04-22

Primary completion

2029-03-02

Completion

2029-03-02

Drugs

Indications